|
"lane hy"的相關文件
顯示項目 11-35 / 43 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 中國醫藥大學 |
2005 |
A functional polymorphism in the promoter region of the tryptophan hydroxylase gene is associated with alcohol dependence in one aboriginal group in Taiwan
|
Sun, HS; Fann, CSJ; Lane, HY; Chang, YT; Chang, CJ; Liu, YL; Cheng, ATA |
| 中國醫藥大學 |
2005 |
Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics
|
Lane, HY; Lee, CC; Liu, YC; Chang, WH |
| 中國醫藥大學 |
2005 |
Regular-dose risperidone on QTc intervals
|
Chiu, CC; Chang, WH; Huang, MC; Chin, YW; Lane, HY |
| 中國醫藥大學 |
2005 |
Doparnine D-3 receptor Ser9GIy polymorphism and risperidone response
|
Lane, HY; Hsu, SK; Liu, YC; Chang, YC; Huang, CH; Chang, WH |
| 中國醫藥大學 |
2005 |
Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics
|
Lane, HY; Lee, CC; Liu, YC; Chang, WH |
| 中國醫藥大學 |
2004 |
Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome
|
Su, KP; Lane, HY; Chuang, CL; Chen, KP; Shen, WW |
| 中國醫藥大學 |
2004 |
Effects of dopamine D-2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function
|
Lane, HY; Lee, CC; Chang, YC; Lu, CT; Huang, CH; Chang, WH |
| 中國醫藥大學 |
2004 |
Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia
|
Chiu, CC; Lane, HY; Huang, MC; Liu, HC; Jann, MW; Hon, YY; Chang, WH; Lu, ML |
| 中國醫藥大學 |
2004 |
Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances
|
Lu, ML; Lane, HY; Lin, SK; Chen, KP; Chang, WH |
| 中國醫藥大學 |
2004 |
Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants
|
Lane, HY; Chang, YC; Chiu, CC; Lee, SH; Lin, CY; Chang, WH |
| 中國醫藥大學 |
2004 |
Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants
|
Lane, HY; Chang, YC; Chiu, CC; Lee, SH; Lin, CY; Chang, WH |
| 中國醫藥大學 |
2004 |
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to antipsychotics for the treatment of schizophrenia
|
Tsai, GC; Lane, HY; Yang, PC; Chong, MY; Lange, N |
| 中國醫藥大學 |
2004 |
Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confounders
|
Lane, HY; Lin, CC; Huang, CH; Chang, YC; Hsu, SK; Chang, WH |
| 中國醫藥大學 |
2004 |
Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confounders
|
Lane, HY; Lin, CC; Huang, CH; Chang, YC; Hsu, SK; Chang, WH |
| 中國醫藥大學 |
2004 |
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to antipsychotics for the treatment of schizophrenia
|
Tsai, GC; Lane, HY; Yang, PC; Chong, MY; Lange, N |
| 中國醫藥大學 |
2004 |
Effects of dopamine D-2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function
|
Lane, HY; Lee, CC; Chang, YC; Lu, CT; Huang, CH; Chang, WH |
| 中國醫藥大學 |
2004 |
Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia
|
Chiu, CC; Lane, HY; Huang, MC; Liu, HC; Jann, MW; Hon, YY; Chang, WH; Lu, ML |
| 中國醫藥大學 |
2003 |
Adjunctive fluvoxamine with clozapine
|
Lu, ML; Lane, HY |
| 中國醫藥大學 |
2003 |
QTc intervals are not prolonged in young healthy patients with recommended dosage of risperidone
|
Chiu, CC; Lane, HY; Huang, MC; Chang, WH |
| 中國醫藥大學 |
2003 |
Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia
|
Lane, HY; Chang, YC; Cheng, YC; Liu, GC; Lin, XR; Chang, WH |
| 中國醫藥大學 |
2003 |
Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia
|
Lane, HY; Chang, YC; Cheng, YC; Liu, GC; Lin, XR; Chang, WH |
| 中國醫藥大學 |
2003 |
Refining pharmacogenetic research in schizophrenia: Control for patient-related variables
|
Lane, HY; Chang, YC; Huang, CL; Chang, WH |
| 中國醫藥大學 |
2003 |
Refining pharmacogenetic research in schizophrenia: Control for patient-related variables
|
Lane, HY; Chang, YC; Huang, CL; Chang, WH |
| 國立臺灣大學 |
2002-05 |
Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study.
|
Lane, HY; Guo, SC; Hwang, TJ; Chen, YS; Cheng, JJ; Lee, YC; Hong, CJ; Hwu, HG; Chang, WH |
| 中國醫藥大學 |
2002 |
Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: A pilot study
|
Lane, HY; Guo, SC; Hwang, TJ; Chen, YS; Cheng, JJ; Lee, YC; Hong, CJ; Hwu, HG; Chang, WH |
顯示項目 11-35 / 43 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
